216
Participants
Start Date
May 2, 2019
Primary Completion Date
December 29, 2023
Study Completion Date
December 29, 2023
sacubitril/valsartan
"Target dose 3.1 mg/kg bid~Formulations:~Tablets (50, 100, 200 mg) Granules \[12.5 mg (4 granules), 31.25 mg (10 granules), in capsules\] Liquid (1 mg/ml, 4 mg/ml, prepared from tablets)"
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Sofia
Novartis Investigative Site, Soweto
Novartis Investigative Site, Innsbruck
Novartis Investigative Site, Zagreb
Novartis Investigative Site, New York
Novartis Investigative Site, Taipei
Novartis Investigative Site, Torino
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkoknoi
Novartis Investigative Site, Beirut
Novartis Investigative Site, Berlin
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Pittsburgh
Novartis Investigative Site, Philadelphia
Novartis Investigative Site, Milan
Novartis Investigative Site, Bergamo
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Charlotte
Novartis Investigative Site, Atlanta
Novartis Investigative Site, St. Petersburg
Novartis Investigative Site, Izmir
Novartis Investigative Site, Konak-Izmir
Novartis Investigative Site, Bologna
Novartis Investigative Site, Indianapolis
Novartis Investigative Site, Florence
Novartis Investigative Site, Yangsan
Novartis Investigative Site, Minneapolis
Mayo Clinic - Rochester, Rochester
Novartis Investigative Site, St Louis
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Stuttgart
Novartis Investigative Site, Tainan City
Novartis Investigative Site, Paris
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Napoli
Novartis Investigative Site, Beersheba
Novartis Investigative Site, Los Angeles
Novartis Investigative Site, Erlangen
Novartis Investigative Site, Loma Linda
Novartis Investigative Site, Palo Alto
Novartis Investigative Site, New Delhi
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Singapore
Novartis Investigative Site, Moscow
Novartis Investigative Site, El Achrafiyé
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Singapore
Novartis Investigative Site, Kochi
Novartis Investigative Site, Boston
Novartis Investigative Site, Ann Arbor
Novartis Investigative Site, Salta
Novartis Investigative Site, Edmonton
Novartis Investigative Site, Toronto
Novartis Investigative Site, Prague
Novartis Investigative Site, Helsinki
Novartis Investigative Site, Budapest
Novartis Investigative Site, Ahmedabad
Novartis Investigative Site, Roma
Novartis Investigative Site, Ōbu
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Ōmura
Novartis Investigative Site, Bunkyo Ku
Novartis Investigative Site, Setagaya-ku
Novartis Investigative Site, Shinjuku Ku
Novartis Investigative Site, Toyama
Novartis Investigative Site, Saitama
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Carnaxide
Novartis Investigative Site, Coimbra
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Esplugues de Llobregat
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Ankara
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY